Company intelligence
Basel Area Life Sciences Supercluster
Your most valuable discovery.
About Basel Area Life Sciences Supercluster
Welcome to the Basel Area, Europe’s transformative life sciences supercluster. For companies at every stage and any scale looking to expand in Europe, our destination is your most valuable discovery. Together, our talent, ecosystem, location and lifestyle are bringing science to life. The Basel Area Life Sciences Supercluster is Europe’s most concentrated destination for biotech, pharma, healthtech and medtech innovation — and home to the highest density of life sciences professionals anywhere in the world. Spanning Switzerland, France, and Germany, it unites more than 800 companies, 1,000 research groups, and nearly 35,000 life sciences experts across three nations into a single, end-to-end ecosystem designed to accelerate innovation from lab to launch. Anchored by global leaders like Roche and Novartis, and powered by leading institutions such as ETH Zurich and the University of Basel, the region is complemented by a dynamic network of startups, research institutes, and commercial partners that connect peers and pioneers across every stage of the value chain. Its borderless location delivers triple the talent and market access with zero friction — supported by one of Europe’s most competitive tax rates, generous R&D incentives, and a globally recognized quality of life. In a world of market variables, the Basel Area offers life sciences companies a constant: Swiss stability with a European spark — a turnkey destination that speaks your language and defines your next discovery. Welcome to the Basel Area. Bringing science to life.
Verified activity
Signals from Basel Area Life Sciences Supercluster
4 published signals
Presence & Recognition
Basel Area Life Sciences Supercluster announced that a recent Swissinfo.ch article highlights 800+ life sciences companies, 33,000+ professionals, a Tier 1 global life sciences cluster, CHF 572.3 million invested in Basel startups in 2025, and around CHF 1 billion raised by biotech ventures supported by BaseLaunch since 2017.
Reported by Basel Area Life Sciences Supercluster
Presence & Recognition
Basel Area Life Sciences Supercluster is attending the LSX Congress USA in Boston from 22 to 24 September 2026.
Reported by Basel Area Life Sciences Supercluster
Presence & Recognition
Basel Area Life Sciences Supercluster announced that Senior leaders from biotech, pharma, academia, and investment will convene to explore opportunities and challenges in today's early-stage drug discovery space at the Drug Discovery Innovators & Investors Digital Forum from Drug Discovery World on September 30.
Reported by Kirsten Detrick
Presence & Recognition
Basel Area Life Sciences Supercluster's Chief Representative Kirsten Detrick appeared in a new BioPharm International interview highlighting the importance of integrating talent and market access considerations into location strategy
Reported by Basel Area Life Sciences Supercluster